Industry News
Long-Term Night Shift Working Linked to Breast Cancer
Jul 03, 2013
Researchers have found that women who work night shifts for more than 30 years may be at a higher risk of breast cancer than other women. The study, published in the British Medical Journal (BMJ), was done by researchers in Canada. They analyzed the careers of 1,134 women with breast cancer and 1,179 women without the disease... Read More
Researchers Testing Novel Melanoma Vaccine In Clinical Trial
Jul 03, 2013
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well... Read More
Second Draft NICE Guidance For Aggressive Non-Hodgkin Lymphoma Treatment, PIXUVRI® (Pixantrone)
Jul 03, 2013
Cell Therapeutics, Inc... Read More
Activartis' Cancer Immunotherapy Receives Orphan Drug Designation From FDA
Jul 03, 2013
The US FDA have notified the Austrian biotech company Activartis that Orphan Drug Designation (ODD) has been granted for its innovative Cancer Immunotherapy AV0113. The ODD applies specifically to the use of AV0113 for the treatment of malignant glioma, a very aggressive type of brain cancer. The European drug agency EMA already granted ODD at the end of last year... Read More
New Breast Cancer Test Will Help More Women Avoid Unnecessary Chemotherapy
Jul 03, 2013
A new genetic test for one of the most common forms of breast cancer will help doctors better identify those women who should be considered for chemotherapy, and those who can avoid it, say researchers... Read More
Pathways Identified That Lead To Creation Of Myofibroblasts, That Cause Destructive Runaway Scarring
Jul 03, 2013
Scientists have tracked down and quantified the diverse origins of cells that drive fibrosis, the incurable, runaway wound-healing that scars and ultimately destroys organs such as the lungs, liver and kidneys... Read More
Discovery Of New Proteasome Regulatory Mechanism May Have Implications For Neurodegenerative Diseases And Cancer
Jul 03, 2013
Dysfunction of the ubiquitin-proteasome system is related to many severe neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and certain types of cancer. Such dysfunction is also believed to be related to some degenerative muscle diseases... Read More
New Evidence For The Genetic Bases Of Liver Cancer
Jul 03, 2013
The Asian Cancer Research Group (ACRG), an independent, not-for-profit company in collaboration with BGI, the world's largest genomics organization, and The University of Hong Kong (HKU), jointly announced the publication of findings from a study of recurrent mutations in hepatocellular carcinoma (HCC), one of the most deadly cancers worldwide, in the international journal Genome Research ... Read More
Research Report Breakthrough In The Regulation Of A Key Cancer Drug Target
Jul 03, 2013
There's not much difference between what makes a man and what makes his beer - at least at the molecular level - according to a new study led by Professor John Schwabe at the University of Leicester. Scientists used a powerful technique called protein crystallography to look at 3D structures of protein complexes purified from cultured human cells... Read More
Autophagy Protects Neuroblastoma From Chemotherapy
Jul 03, 2013
Neuroblastomas are pediatric tumors that originate from cells of the embryonic nervous system. The disease can take widely varying clinical courses that range from spontaneous regression to fatal outcomes. Highly aggressive neuroblastomas rarely respond well to chemotherapy... Read More
Previous Page Next Page